S
LONA

SignatureFD’s LeonaBio Inc LONA Stock Holding History

SignatureFD’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-14
Closed – – 3105
2022
Q2 		$0 Buy
+14
New +$1.28K ﹤0.01% 3100
2021
Q4 		– Sell
-160
Closed -$15K – 3101
2021
Q3 		$15K Sell
160
-90
-36% -$9.16K ﹤0.01% 1871
2021
Q2 		$26K Buy
250
+100
+67% +$17.5K ﹤0.01% 1606
2021
Q1 		$28K Hold
150
– – ﹤0.01% 1425
2020
Q4 		$51K Buy
+150
New +$35.4K ﹤0.01% 1059

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BA
Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SignatureFD's LONA Position: Q3 2022 in Review

SignatureFD sold out of LeonaBio Inc (LONA) in Q3 2022, closing a stake of 14 shares.

SignatureFD first reported a position in LONA in Q4 2020 and held it in 5 quarters. The position peaked at $51K in Q4 2020. 98 funds tracked by Wall St. Rank hold LONA as of Q3 2022.

  • SignatureFD reported no remaining LeonaBio Inc position as of Q3 2022 after selling out during the quarter.
  • SignatureFD sold 14 LeonaBio Inc shares in Q3 2022.
  • SignatureFD first reported a position in LeonaBio Inc in Q4 2020 and held it in 5 quarters.
  • SignatureFD's LeonaBio Inc position peaked at $51K in Q4 2020.
  • 98 funds tracked by Wall St. Rank held LeonaBio Inc as of Q3 2022.

Based on SignatureFD's 13F filing for Q3 2022, filed 8 Nov 2022.